Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Clinical Trial
. 2009 May;65(5):510-9.
doi: 10.1002/ana.21642.

Remission of epilepsy after two drug failures in children: a prospective study

Anne T Berg  1 , Susan R Levy, Francine M Testa, Ramona D'Souza
Affiliations
Clinical Trial

Remission of epilepsy after two drug failures in children: a prospective study

Anne T Berg et al. Ann Neurol. 2009 May.

Abstract

Objective: Determine the probability of a more than 1-year remission after failure of a second drug in children prospectively followed from initial diagnosis of epilepsy and then from time of second drug failure. Identify prognostic factors for remission after second drug failure.

Methods: Of 613 children, 128 did not respond favorably to 2 drugs, had a trial of at least a third drug (median, 3), and were followed for more than 1 year (median, 10.1 years) since second drug failure. Product limit and proportional hazards techniques were used to analyze predictors of any 1-year remission (Rem1) and 1- and 3-year remission at last contact (Rem1/3-LC).

Results: Seventy-three patients (57%) had a remission. Repeated remissions and relapses were common. Only 48 (37.5%) achieved Rem1-LC and 28 (23%) Rem3-LC. Idiopathic epilepsy (Rem1: rate ratio [RR], 3.64, p < 0.0001; Rem1-LC: RR, 2.57, p = 0.008) and seizure frequency (Rem1: RR, 0.76, p = 0.003; Rem1-LC: RR, 0.82, p = 0.04 per increase in category) were the most robust predictors. Symptomatic cause was the only correlate of Rem3-LC. Remission before second drug failure did not predict remission after second drug failure.

Interpretation: Remission after second drug failure is common but often temporary. Children who have not responded to two appropriate drugs should be carefully evaluated to maximize therapy and possibly considered for more aggressive treatments.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Overall cumulative probability of any remission and of 1 and 3 year remission at last contact.
Figure 2
Figure 2
Cumulative probability of (a) any remission after second AED failure (b) 1-year remission as of last contact, and (c) 3-year remission at last contact as a function of remission prior to second AED failure.
See this image and copyright information in PMC

Comment in

References

    1. Dlugos D, Sammel M, Strom B, Farrar J. Response to first drug trial predicts outcome in childhood temporal lobe epilepsy. Neurology. 2001;57:2259–2264. - PubMed
    1. Camfield P, Camfield C. Nova Scotia pediatric epilepsy study. In: Jallon P, Berg A, Dulac O, Hauser A, editors. Prognosis of epilepsies. Montrouge France: John Libbey, Eurotext; 2003. pp. 113–126.
    1. Arts WFM, Brouwer OF, Peters ACB, et al. Course and prognosis of childhood epilepsy: 5-year follow-up of the Dutch study of epilepsy in childhood. Brain. 2004;127:1774–1784. - PubMed
    1. Berg AT, Vickrey BG, Testa FM, et al. How long does it take epilepsy to become intractable? A prospective investigation. Ann Neurol. 2006;60:73–79. - PubMed
    1. Spooner CG, Berkovic SF, Mitchell LA, et al. New onset temporal lobe epilepsy in children: lesion on MRI predicts poor seizure outcome. Neurology. 2006;67:2147–2153. - PubMed

Publication types

MeSH terms

Substances